Mahzi Therapeutics Inc.

South San Francisco, CA · Founded 2020 · CIK 0001888808 · Biotech · Private

Therapies for rare genetic neurodevelopmental disorders

mahzi.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$27M
1 Form D · Oct 2021
59 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$26,787,382
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2131BLUE THERAPEUTICS, INC.——
2132ProteoPrinceps, LLC——
2133Rebiotix Inc.—$29M
2134Mahzi Therapeutics Inc.—$27M
2135INVIVO THERAPEUTICS HOLDINGS CORP.—$9.3M
2136Richard Fisher——
2137PLEXYMER, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Stephen FarrDirector
  • Camille SamuelsDirector
  • Shalini SharpDirector
  • Marten SteenDirector
  • Yael WeissDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.